[{"address1": "Life Science & Technology Park", "address2": "Suite  520 1951 NW 7th Avenue", "city": "Miami", "state": "FL", "zip": "33136", "country": "United States", "phone": "844 470 2550", "website": "https://longeveron.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joshua Michael Hare FACC, M.D.", "age": 60, "title": "Co-Founder, Chief Science Officer & Chairman", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 74000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mohamed Wa'el Ahmed Hashad M.B.A.", "age": 61, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 867854, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa A. Locklear M.B.A.", "age": 61, "title": "CFO & Treasurer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 472272, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul T. Lehr J.D.", "age": 55, "title": "International Executive Director, General Counsel & Secretary", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 554055, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Dan  Gincel Ph.D.", "age": 52, "title": "Senior Vice President of Strategic Collaborations & Scientific Affairs", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Nataliya  Agafonova M.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elly  Ryu", "age": 42, "title": "VP & Corporate Controller", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Mannarino", "title": "VP & Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.25, "open": 3.13, "dayLow": 2.9, "dayHigh": 3.42, "regularMarketPreviousClose": 3.25, "regularMarketOpen": 3.13, "regularMarketDayLow": 2.9, "regularMarketDayHigh": 3.42, "beta": 0.411, "forwardPE": -1.2322097, "volume": 2598025, "regularMarketVolume": 2598025, "averageVolume": 10245241, "averageVolume10days": 21264335, "averageDailyVolume10Day": 21264335, "bid": 3.27, "ask": 3.51, "bidSize": 3400, "askSize": 5300, "marketCap": 31586994, "fiftyTwoWeekLow": 0.7707, "fiftyTwoWeekHigh": 35.6, "priceToSalesTrailing12Months": 32.29754, "fiftyDayAverage": 1.9377, "twoHundredDayAverage": 8.178247, "currency": "USD", "enterpriseValue": 20491972, "floatShares": 4715187, "sharesOutstanding": 8116910, "sharesShort": 292858, "sharesShortPriorMonth": 55050, "sharesShortPreviousMonthDate": 1717113600, "dateShortInterest": 1719532800, "sharesPercentSharesOut": 0.0305, "heldPercentInsiders": 0.073130004, "heldPercentInstitutions": 0.00614, "shortRatio": 0.02, "shortPercentOfFloat": 0.038, "impliedSharesOutstanding": 9600910, "bookValue": 1.208, "priceToBook": 2.72351, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -21622000, "trailingEps": -9.6, "forwardEps": -2.67, "lastSplitFactor": "1:10", "lastSplitDate": 1711497600, "enterpriseToRevenue": 20.953, "enterpriseToEbitda": -1.055, "52WeekChange": -0.90208334, "SandP52WeekChange": 0.2086575, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "LGVN", "underlyingSymbol": "LGVN", "shortName": "Longeveron Inc.", "longName": "Longeveron Inc.", "firstTradeDateEpochUtc": 1613140200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "0810e7c7-ed9c-3408-947e-be0c34d084bb", "messageBoardId": "finmb_410711455", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.29, "targetHighPrice": 15.0, "targetLowPrice": 10.75, "targetMeanPrice": 12.58, "targetMedianPrice": 12.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 2291000, "totalCashPerShare": 0.361, "ebitda": -19420000, "totalDebt": 1896000, "quickRatio": 0.466, "currentRatio": 0.71, "totalRevenue": 978000, "debtToEquity": 62.348, "revenuePerShare": 0.43, "returnOnAssets": -0.8086, "returnOnEquity": -2.15135, "freeCashflow": -9100500, "operatingCashflow": -16240000, "revenueGrowth": 0.964, "grossMargins": 0.48466, "operatingMargins": -7.4634995, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-22"}]